Pavel V. Avdonin
Moscow, MOW 119334, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Interpretable Machine Learning with SHAP Identifies Key Biomarkers in a Multi-Factorial Spectrum of Age-Related Neurological and Metabolic Conditions.
Journal: International journal of molecular sciences
Published: January 06, 2026
Personalised treatment of patients with immune thrombotic thrombocytopenic purpura
Journal: Terapevticheskii arkhiv
Published: May 26, 2025
Immunity and Coagulation in COVID-19.
Journal: International journal of molecular sciences
Published: August 19, 2024
Immunological Profile and Markers of Endothelial Dysfunction in Elderly Patients with Cognitive Impairments.
Journal: International journal of molecular sciences
Published: December 10, 2023
Searching for New Biomarkers to Assess COVID-19 Patients: A Pilot Study.
Journal: Metabolites
Published: October 23, 2023
Successful Treatment of Acquired Thrombotic Thrombocytopenic Purpura With Caplacizumab Combined With Plasma Exchanges and Immune Suppression in 3 Children.
Journal: Journal of pediatric hematology/oncology
Published: October 19, 2023
A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS.
Journal: Biomolecules
Published: September 19, 2023
Synergistic Interaction of 5-HT1B and 5-HT2B Receptors in Cytoplasmic Ca2+ Regulation in Human Umbilical Vein Endothelial Cells: Possible Involvement in Pathologies.
Journal: International journal of molecular sciences
Published: June 06, 2023
Albumin Is a Component of the Esterase Status of Human Blood Plasma.
Journal: International journal of molecular sciences
Published: February 28, 2023
SARS-CoV-2 Receptors and Their Involvement in Cell Infection.
Journal: Biochemistry (Moscow) Supplement. Series A, Membrane and cell biology
Published: July 10, 2022
Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1).
Journal: Journal of evolutionary biochemistry and physiology
Published: March 06, 2022
Last Updated: 09/26/2026